CancerCare Manitoba’s Department of Epidemiology and Cancer Registry is dedicated to providing support to investigators interested in using health information from the Manitoba Cancer Registry, as well as other linkable data sources. The Department has knowledgeable and skilled staff who can work with health researchers.
The Department can provide the following services:
Individuals or groups seeking information please submit an email to email@example.com.
Please provide the following information in your email:
If you have any questions about this process or the services the department provides, please email firstname.lastname@example.org. We will do our best to meet all reasonable deadlines.
Nurses of the chemotherapy treatment room at CancerCare Manitoba provide cancer treatment and supportive care to approximately 100 patients daily.
If participants enrolled in the study will need:
then you need approval from Chemotherapy/Supportive Therapy.
The Clinical Trials Unit (CTU) facilitates and coordinates clinical research in the areas of prevention, treatment, palliation and quality of life. Data collected from our participation in national and international research has influenced the standard treatments used today. Through clinical trials, patients are provided with the opportunity to access state-of-the-art treatments and to raise the profile of CCMB as a significant contributor to the research being done worldwide.
Of the approximately 120 adult and pediatric clinical trials open to participation each year, the CTU enters an average of 300 new patients while continuing to follow thousands of participants in long-term follow up. Clinical research conducted at CCMB incorporates studies offered through cooperative groups, pharmaceutical companies and in-house research. Patients participating in these studies have access to some of the most innovative and cutting edge treatments, tests or prevention tools available.
The CTU has extensive experience across a spectrum of clinical trial activities, and offers the following services:
Questions, contact our main office (McDermot Ave) at 204-787-4156.
Will the Researcher Require Information Contained Within the BMT Registry?
Is the Study Considered Translational Research?
Do You Need Someone to Screen Patients for Eligibility?
Do you Need Someone to Obtain Patient Consent?
Do you Need Someone to Conduct Patient Evaluations?
Do you Need Someone to Collect Patient Information?
The CancerCare Manitoba Health Records Department manages patient health information as set out by the Personal Health Information Act of Manitoba. The Health Records Department is responsible for ensuring all patient hardcopy health records are kept secure, up-to-date, protected and accessible for patient care, administration, and research.
The Health Records Department supports research by providing investigators hardcopy with:
Our office is open Monday to Friday from 08:00 to 17:00 hours.
In order to obtain access to patient hardcopy health records, investigators must first receive approval from the CancerCare Manitoba Research Resource Impact Committee (RRIC). You will be required to:
Booking Workstations for Chart Review
Workstations in Health Records (ON 2092) are available to accommodate Researchers review of electronic and hardcopy patient charts on approved research studies.
Please contact File Control Services in Health Records to;
The workstations are available Monday to Friday 08:00 - 17:00 hrs.
To book a workstation, please contact the File Control Clerk at 204-787-4017.
For more information about how to access patient hardcopy health records for approved research purposes, contact the Senior File Control Clerk at (204) 787-4017.
The information provided here is meant to provide guidance and highlight typical information required as part of the submission process. By including this information, we can quickly review and identify any impacts resulting from studies.
Hematology Laboratory at CancerCare Manitoba (CCMB) provides service to all patients under active care at CCMB and on average sees 150 patients per day. If you require blood to be drawn as part of your study, special procedures such as a bone marrow aspirate and/or biopsy or if you need to have samples shipped out, approval is required by the Hematology Lab.
The Provincial Pharmacy program at CancerCare Manitoba has an Investigational Drug Services (IDS) area, staffed by pharmacists and pharmacy assistants. These professionals ensure good clinical practice is followed for all clinical trial duties they are delegated.
IDS staff ensure that all drug provided as part of a clinical trial are handled in accordance with Health Canada regulations for clinical trials. Services provided by IDS include; ordering, receiving, completing accountability, dispensing and preparation, storage and destruction of trial associated drug. Trial related documentation is maintained and stored by IDS as per Health Canada regulations. IDS staff will liaise with the study investigators and/or sponsors as required. If required, prescription development and patient education may also be provided.
If you are working on a trial that may require pharmacy services please contact the IDS Pharmacy at (204)787-4359 to inquire about our services and fee structure.
The Provincial Pharmacy program maintains an electronic database of all restricted or non-formulary medication requests. The database will list the patient, prescriber, the requested therapy, and the outcome of the request.
If you have any questions about this database please contact the Pharmacy Data Manager at (204)787-4263.
Preventative maintenance, calibration and/or servicing of medical equipment
The Department of Medical Engineering may be able to offer this service to research groups provided they have expertise with the specific piece of equipment. Some equipment can be very complex and calibration or servicing of that specific device may only be possible if an individual has taken a formal training course to do so. These training courses may need to be purchased by the owner of the equipment and subsequently taken by members of the Department of Medical Engineering to make calibration/servicing by this group possible.
Incoming inspection (electrical and CSA) of new medical device
This inspection ensures that electrical equipment conform to federal and provincial regulations regarding safe use of electrical equipment. All electrical equipment brought into CCMB must undergo this incoming inspection by the Medical Engineering group.
Design/fabrication of devices
The Department of Medical Engineering has the capabilities and expertise to design and manufacture custom devices both mechanical and electrical and this skill set may fit with that required by a research program.
Credentialing of radiation therapy techniques
The Radiation Therapy Physics group is responsible for testing the accuracy of new radiation treatment techniques. Some clinical trials require this testing be performed and the results submitted to a standards committee before an institution is allowed to participate in the trial.
Submission of radiation therapy treatment data
The Radiation Therapy Physics group is responsible for overseeing the collection of patient specific radiation therapy data required by clinical trials.
For researchers with questions, please contact Jeff Bews at (204) 787 1804 or email@example.com
There are approximately 100 nurses working in at least 15 different DSG clinics at CancerCare Manitoba (CCMB), St. Boniface and MacCharles Units. Nurses are key contributors to the implementation of cancer treatment, support for patients and families and are integral members of the care team.
If you need nurses to be involved in your study such as:
then it needs approval from nursing.
Patient and Family Support Services, operating within the provincial mandate of CancerCare Manitoba, is a multidisciplinary team of professionals working collaboratively to help meet the social, emotional, nutritional, informational, psychological, spiritual, rehabilitation and practical needs of those affected by cancer and their families throughout the diagnostic, treatment and/or follow-up phases of cancer care. It encompasses issues of prevention, survivorship, recurrence, palliative care and bereavement.
Patient and Family Support Services includes six distinct but related services: Psychosocial Oncology (including Spiritual Care), Nutrition Services, Rehabilitation Services (Speech Language Pathology), Breast Cancer Centre of Hope, Patient and Family Resource Centre and Guardian Angel Caring Room .
Services are provided at all CancerCare Manitoba Units, ie MacCharles Site (675 McDermot Avenue), St. Boniface Unit, and Misericordia site (Breast Cancer Centre of Hope).
We encourage investigators to consider collaborating with staff within Patient and Family Support Services if their research involves one of these specialty areas of cancer care.
CancerCare Manitoba’s Patient and Family Support Services supports research by:
If it is anticipated that patients and or families may feel anxiety or emotional distress as a result of participation in a study, or, if anxiety or emotional distress might be uncovered through participation in a study, it is recommended that the following paragraph be included in the information for study participants. Sign off from the Director of Patient and Family Support Services will also be required.
"Participation in this study may be upsetting or distressing to you as you recall your own cancer experience, or the experience of your family member. If you would like to talk to someone about this, there is support available through CancerCare Manitoba Patient and Family Support Services. Please call 204-787-2109 or toll free 1-800-561-1026, or ask the research study staff to refer you."
Radiation Therapy treatment planning uses images from the CT Simulator to design treatment plans, by means of a treatment planning computer, that will deliver a prescribed dose of radiation in accordance with a Radiation Oncologist's prescription to a defined target volume and to consider and limit the dose to normal structures (organs at risk, or OARs). 3D and/or IMRT treatment techniques are used to design the plans. Radiation Therapy treatment is delivered using highly sophisticated equipment and involves a high degree of accuracy. During the course of radiation, medical imaging is used to ensure the patient is in the correct position for every treatment.
CancerCare Manitoba operates three provincial, population-based, organized screening programs: BreastCheck, CervixCheck, and ColonCheck.
BreastCheck provides screening mammography to women 50 years of age and older. The BreastCheck registry includes information on mammography results, follow-up tests, and final diagnoses.
CervixCheck operates a registry of all Pap test results, coloposcopy, and biopsy procedures, and HPV vaccination for women 18 to 69 years of age.
ColonCheck provides fecal occult blood tests to men and women 50 to 74 years of age. The ColonCheck registry includes the results of the FOBT, follow-up tests (colonoscopy), and final diagnoses. The programs also provide health promotion and public education for the public and health care professionals.
For researchers with questions about the screening programs, please contact any of the following individuals:
Laura Coulter, CCMB Screening Programs Manager, 204-788-8084